BioAge Labs (BIOA) Share-based Compensation (2023 - 2026)

BioAge Labs has disclosed Share-based Compensation across 4 years of filings, most recently posting $4.3 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $4.3 million, up 44.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.0 million (up 43.21% YoY), and the FY2025 annual result was $11.7 million, up 67.52% from the prior year.
• Share-based Compensation came in at $4.3 million for Q1 2026 at BioAge Labs, up from $2.7 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.3 million in Q1 2026 to a low of $757000.0 in Q3 2023.
• The 4-year median for Share-based Compensation is $2.7 million (2024), against an average of $2.2 million.
• Across the five-year window, Share-based Compensation surged 254.76% in 2024 and advanced 0.04% in 2025, its largest moves.
• BioAge Labs' Share-based Compensation stood at $767000.0 in 2023, then soared by 254.76% to $2.7 million in 2024, then advanced by 0.04% to $2.7 million in 2025, then soared by 56.36% to $4.3 million in 2026.
• The last three Share-based Compensation figures came in at $4.3 million (Q1 2026), $2.7 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.